Viewing Study NCT07161258

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:12 AM
Ignite Modification Date: 2026-01-04 @ 7:50 AM
Study NCT ID: NCT07161258
Status: RECRUITING
Last Update Posted: 2025-12-12
First Post: 2025-08-20
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Pharmacokinetics (PK), Pharmacodynamics (PD), Safety and Tolerability Study of Fenebrutinib in Children and Adolescents With Relapsing Multiple Sclerosis (RMS)
Sponsor: Hoffmann-La Roche
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Relapsing Multiple Sclerosis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Pediatric multiple sclerosis View
None Pediatric MS View
None Children MS View
None Children multiple sclerosis View
None Adolescent multiple sclerosis View
None Pediatric fenebrutinib View